Achieve Life Sciences
ACHV
70 hedge funds and large institutions have $57.5M invested in Achieve Life Sciences in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 4 closing their positions.
121,200% more call options, than puts
Call options by funds: $2.43M | Put options by funds: $2K
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
125% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 12
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
9% more funds holding
Funds holding: 64 → 70 (+6)
1.79% less ownership
Funds ownership: 49.3% → 47.52% (-1.8%)
29% less capital invested
Capital invested by funds: $81.2M → $57.5M (-$23.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DI
DUMAC Inc
Durham,
North Carolina
|
+$227K |
| 2 |
JP Morgan Chase
New York
|
+$201K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$198K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$164K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$144K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
-$1.93M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$940K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$864K |
| 4 |
Goldman Sachs
New York
|
-$379K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$227K |
ACHV Hedge Fund Activity: Q4 2024 in Review
70 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2024, worth a combined $57.5M — down 29% from $81.2M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ACHV positions and 4 closed out — a net gain of 7 holders — while 27 added to existing stakes and 12 trimmed.
The largest buyer was DUMAC Inc, opening a new position worth an estimated $227K. The largest seller was Shay Capital, cutting an estimated $1.93M.
- 70 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2024, up from 64 in Q3 2024.
- Funds reported $57.5M of Achieve Life Sciences stock for Q4 2024, down 29% quarter-over-quarter.
- 11 funds opened new Achieve Life Sciences positions in Q4 2024 and 4 closed out, a net change of +7 holders.
- The largest Achieve Life Sciences buyer in Q4 2024 was DUMAC Inc, an estimated $227K added.
- The largest Achieve Life Sciences seller in Q4 2024 was Shay Capital, an estimated $1.93M sold.
Based on aggregated 13F filings for Q4 2024.